BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 916187)

  • 41. [Clinical experience with S-6436 in patients with urinary tract infections (author's transl)].
    Urata H; Komeda K; Tochigi H; Morishita F; Horiuchi E
    Jpn J Antibiot; 1977 Oct; 30(10):829-34. PubMed ID: 338939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical results of cefadroxil in children and pharmacokinetics of the drug (author's transl)].
    Takimoto M; Cho K; Yoshioka H; Sanae N; Maruyama S
    Jpn J Antibiot; 1981 Feb; 34(2):140-2. PubMed ID: 7253191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cephalexin levels in the bronchial secretion of children (author's transl)].
    Daschner F
    MMW Munch Med Wochenschr; 1977 Mar; 119(10):339-40. PubMed ID: 403412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cephalexin in daily practice. A multi-center study of Swiss pediatricians and ENT-specialists (author's transl)].
    Hagmann R
    Schweiz Rundsch Med Prax; 1978 Oct; 67(40):1471-7. PubMed ID: 704538
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Tanimoto H; Nakamori Y
    Jpn J Antibiot; 1988 Sep; 41(9):1319-24. PubMed ID: 3241331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical experience with cefadroxil dry syrup in pediatric infections (author's transl)].
    Fujita M; Kuronuma T; Aoyama R; Nagata K; Izumi Y
    Jpn J Antibiot; 1981 Feb; 34(2):143-5. PubMed ID: 7253192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cephalexin in lower respiratory tract infections.
    Raff MJ
    Postgrad Med J; 1983; 59 Suppl 5():32-9. PubMed ID: 6364088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical experience with cefadroxil powder for syrup in treatment of infections in children (author's transl)].
    Nagamatsu I; Takase A; Nohira C
    Jpn J Antibiot; 1981 Jun; 34(6):929-33. PubMed ID: 7289041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cephalexin preparation with prolonged activity (author's transl)].
    Maekawa H; Takagishi Y; Iwamoto K; Doi Y; Ogura T
    Jpn J Antibiot; 1977 Aug; 30(8):631-8. PubMed ID: 909151
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cephalexin in pulmonary infections in children].
    Paschetta G; De Biasi V
    Minerva Pediatr; 1971 Dec; 23(49):2065-71. PubMed ID: 5131194
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical studies on cefadroxil in pediatrics (author's transl)].
    Terashima I; Nakamura A; Okimoto Y; Kurosaki T; Uehara S
    Jpn J Antibiot; 1981 Jan; 34(1):25-32. PubMed ID: 7017196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cephalexin in the treatment of upper respiratory tract infections.
    Disney FA
    Postgrad Med J; 1983; 59 Suppl 5():28-31. PubMed ID: 6364087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Oral cephalexin therapy of osteomyelitis (author's transl)].
    Endler M; Hackel H
    Wien Med Wochenschr; 1979 Feb; 129(4):107-11. PubMed ID: 425547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical results with cefadroxil (BL-S578) for respiratory infections (author's transl)].
    Suzuki H; Kunieda T; Osakabe Y; Nakagami K; Satomi T; Saruta E; Noguchi E
    Jpn J Antibiot; 1980 Mar; 33(3):354-7. PubMed ID: 7401308
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
    Hayashi I; Ohnuma K
    Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical experience of cefadroxil for respiratory infections (author's transl)].
    Kajiki A; Takamoto M; Ishibashi T
    Jpn J Antibiot; 1980 Dec; 33(12):1274-6. PubMed ID: 7241800
    [No Abstract]   [Full Text] [Related]  

  • 57. [Laboratory and clinical studies on ceftizoxime in the field of pediatrics (author's transl)].
    Toyonaga Y; Kurosu Y; Sugita M; Kawamura G; Okuyama M; Yoshino N; Hori M; Takahashi T
    Jpn J Antibiot; 1982 Jan; 35(1):9-32. PubMed ID: 6279916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical evaluation of long-acting preparation of cephalexin (S-6436 and S-6437) in the infectious diseases in the otolaryngological field (author's transl)].
    Baba S; Nishimura T; Ito H; Maruo T; Muto N
    Kansenshogaku Zasshi; 1977 Jun; 51(6):356-64. PubMed ID: 411850
    [No Abstract]   [Full Text] [Related]  

  • 59. Cephalexin therapy for infections complicated by age and concurrent diseases. A study in general practice.
    Cooke DM
    Chemotherapy; 1979; 25(6):356-61. PubMed ID: 520078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
    Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
    Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.